Theratechnologies Enterprise Value Over E B I T D A from 2010 to 2024

TH Stock  CAD 1.70  0.02  1.19%   
Theratechnologies Enterprise Value Over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value Over EBITDA is likely to drop to -8.16. During the period from 2010 to 2024, Theratechnologies Enterprise Value Over EBITDA quarterly data regression pattern had sample variance of 512.4 M and median of (15.98). View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(7.77)
Current Value
(8.16)
Quarterly Volatility
22.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Theratechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theratechnologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Interest Expense of 12.7 M or Selling General Administrative of 18.9 M, as well as many indicators such as Price To Sales Ratio of 0.56, Dividend Yield of 0.0 or Days Sales Outstanding of 62.42. Theratechnologies financial statements analysis is a perfect complement when working with Theratechnologies Valuation or Volatility modules.
  
This module can also supplement various Theratechnologies Technical models . Check out the analysis of Theratechnologies Correlation against competitors.
To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.

Pair Trading with Theratechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theratechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theratechnologies will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Theratechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Theratechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Theratechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Theratechnologies to buy it.
The correlation of Theratechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Theratechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Theratechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Theratechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:
Check out the analysis of Theratechnologies Correlation against competitors.
To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Please note, there is a significant difference between Theratechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theratechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theratechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.